European Regulatory Roundup, December 2022: Repositioning The MDR For A Better Year In 2023

2022 ended on as positive a note as could have been wished for in terms of setting the scene for a more effective implementation of the MDR. But has too much damage already been done?

Top Stories EU

As 2022 drew to a close, the European Commission, after much persuasion by all stakeholders in the medtech sector, came up with proposals intended to address some of the greatest challenges with the implementation of the Medical Device Regulation. This was mainly in a bid to prevent the unnecessary removal of even more medtech products from the EU market.

Its proposals, if enforced as expected in early 2023, will effectively change of the course of implementation of the MDR.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.